Medicare Enrolled

Dr. Amir Hossein Marvasti

Ophthalmology · Orange, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
363 S MAIN ST STE 100, Orange, CA 92868
7147711213
In practice since 2014 (11 years)
NPI: 1568882751 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marvasti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marvasti? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marvasti

Dr. Amir Hossein Marvasti is an ophthalmology specialist in Orange, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Marvasti performed 1,756 Medicare services across 1,463 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marvasti received a total of $20,827 from 33 pharmaceutical and/or device companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marvasti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 1,756 Medicare services $20,827 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,756
Medicare services
Bottom 48% in CA for ophthalmology
1,463
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
350 $33 $150
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
325 $74 $175
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
283 $112 $300
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
227 $105 $250
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
156 $34 $150
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
91 $50 $150
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
90 $27 $150
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
61 $297 $500
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
47 $31 $150
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
33 $23 $150
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
25 $14 $27
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
25 $8 $100
CT scan of cornea
A computed tomography scan used to create detailed images of the cornea, the clear front part of the eye.
24 $32 $150
Cataract removal with artificial lens and drainage device insertion
Surgical removal of the eye's natural lens followed by the insertion of an artificial lens and a drainage device into the front chamber of the eye.
19 $464 $1,500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
16.8% medium
81.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$20,827
Total received (2018-2024)
Avg $2,975/year across 7 years
Top 10% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
286
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,729 (70.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,097 (29.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,972
2023
$3,437
2022
$3,173
2021
$5,522
2020
$1,121
2019
$1,628
2018
$975

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Glaukos Corporation
$2,203
LENSAR, Inc.
$500
ABBVIE INC.
$481
Bausch & Lomb Americas Inc.
$480
Alcon Vision LLC
$392
Nova Eye, Inc.
$225
BIOTISSUE HOLDINGS INC.
$149
Sight Sciences, Inc.
$132
Tarsus Pharmaceuticals, Inc.
$115
Johnson & Johnson Surgical Vision, Inc.
$56
RxSight Inc
$51
Mallinckrodt Hospital Products Inc.
$46
Amgen Inc.
$46
Oyster Point Pharma, Inc.
$28
Dompe US, Inc.
$24
Thea Pharma Inc.
$23
Ocular Therapeutix, Inc.
$21
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
Glaukos Corporation
$3,528
RxSight Inc
$3,180
Alcon Vision LLC
$3,137
Sight Sciences, Inc.
$1,644
ABBVIE INC.
$1,164
Alcon Laboratories Inc
$857
Bausch & Lomb Americas Inc.
$604
Carl Zeiss Meditec USA, Inc.
$596
Bausch & Lomb, a division of Bausch Health US, LLC
$571
Dompe US, Inc.
$557
Omeros Corporation
$529
LENSAR, Inc.
$500
Aerie Pharmaceuticals, Inc.
$497
Ocular Therapeutix, Inc.
$450
Sun Pharmaceutical Industries Inc.
$373
Allergan, Inc.
$359
SUN PHARMACEUTICAL INDUSTRIES INC.
$308
Oyster Point Pharma, Inc.
$293
Nova Eye, Inc.
$225
Carl Zeiss Meditec, Inc.
$204
GLAUKOS CORPORATION
$189
BIOTISSUE HOLDINGS INC.
$149
BioTissue Holdings, Inc.
$140
Mallinckrodt Hospital Products Inc.
$126
Novartis Pharmaceuticals Corporation
$124
Apellis Pharmaceuticals, Inc.
$123
Tarsus Pharmaceuticals, Inc.
$115
Johnson & Johnson Surgical Vision, Inc.
$96
Thea Pharma Inc.
$60
Kala Pharmaceuticals, Inc.
$46
Amgen Inc.
$46
EYEVANCE PHARMACEUTICALS LLC
$20
STAAR SURGICAL COMPANY
$16
Top 3 companies account for 47.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALDEN SCLERAL ZENLENS · ARGOS · ARTEVO 800 · AcrySof · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · BROMSITE · CE-marked KXLA system · CEQUA · Centurion · Cequa · Clareon · CyPass · DEXTENZA · DURYSTA · Flarex · HYDRUS Microstent · ILUX · INVELTYS · IOL · ISTENT INJECT W · IYUZEH · KXL SYSTEM · KXL system (not refurbished) · KXL system (refurbished) · LENSAR LASER SYSTEM · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX SM · LUMIGAN · LenSx · MIEBO · NGENUITY · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · Omidria · PROKERA · PanOptix · Photrexa · QUATERA 700 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · RXSIGHT INJECTOR HANDPIECE · ReSTOR · ReSure Sealant · Rocklatan · STELLARIS · TEARCARE SYSTEM · TECNIS IOL · TEPEZZA · TYRVAYA · TearCare SmartLid · Tecnis Simplicity · VUITY · VYZULTA · VisuMax · Wavelight · Wavelight Refractive Suite · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · enVista MX60 IOL · iStent Trabecular Micro-Bypass System Model iS3 · iStent inject Trabecular Micro-Bypass Stent System · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (71%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for ophthalmology in CA.

Looking for an ophthalmology specialist in Orange?
Compare ophthalmologists in the Orange area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
467
Per 100K population
14.8
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JOSEPH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marvasti is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marvasti experienced with corneal topography and eye depth measurement?
Based on Medicare claims data, Dr. Marvasti performed 350 corneal topography and eye depth measurement services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marvasti receive payments from pharmaceutical companies?
Yes. Dr. Marvasti received a total of $20,827 from 33 companies across 286 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marvasti's costs compare to other ophthalmologists in Orange?
Dr. Marvasti's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marvasti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →